Last updated: 16 May 2024 at 4:06pm EST

Matthew Vincent Dolan Net Worth




The estimated Net Worth of Matthew Vincent Dolan is at least $6.66 Million dollars as of 15 May 2024. Matthew Dolan owns over 2,423 units of Dexcom Inc stock worth over $2,743,935 and over the last 3 years Matthew sold DXCM stock worth over $3,917,253.

Matthew Dolan DXCM stock SEC Form 4 insiders trading

Matthew has made over 10 trades of the Dexcom Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Matthew sold 2,423 units of DXCM stock worth $306,703 on 15 May 2024.

The largest trade Matthew's ever made was selling 6,710 units of Dexcom Inc stock on 12 March 2024 worth over $901,891. On average, Matthew trades about 2,025 units every 61 days since 2022. As of 15 May 2024 Matthew still owns at least 40,075 units of Dexcom Inc stock.

You can see the complete history of Matthew Dolan stock trades at the bottom of the page.



What's Matthew Dolan's mailing address?

Matthew's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.

Insiders trading at Dexcom Inc

Over the last 19 years, insiders at Dexcom Inc have traded over $724,717,982 worth of Dexcom Inc stock and bought 165,450 units worth $3,489,100 . The most active insiders traders include Sean Carney, Kim D Blickenstaff, and Steven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of $892,438. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth $29,458.



What does Dexcom Inc do?

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.



What does Dexcom Inc's logo look like?

Dexcom Inc logo

Complete history of Matthew Dolan stock trades at Dexcom Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
15 May 2024 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 2,423 $126.58 $306,703
15 May 2024
40,075
15 Apr 2024 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 1,990 $137.81 $274,242
15 Apr 2024
42,377
15 Mar 2024 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 4,203 $130.21 $547,273
15 Mar 2024
44,367
12 Mar 2024 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 6,710 $134.41 $901,891
12 Mar 2024
48,570
1 Sep 2023 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 56 $102.32 $5,730
1 Sep 2023
33,569
16 Mar 2023 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 2,303 $115.00 $264,845
16 Mar 2023
33,569
10 Mar 2023 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 6,229 $106.27 $661,956
10 Mar 2023
35,872
6 Mar 2023 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 226 $114.40 $25,854
6 Mar 2023
26,536
1 Sep 2022 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 5 $81.63 $408
1 Sep 2022
26,536
15 Mar 2022 Matthew Vincent Dolan
EVP Strategy and Corporate Dev
Sale 2,186 $424.68 $928,350
15 Mar 2022
6,634


Dexcom Inc executives and stock owners

Dexcom Inc executives and other stock owners filed with the SEC include: